Brief: Kronos Bio Reports Recent Business Progress And Q4 And Full-Year 2022 Financial Results
15/03/2023 20:09
March 15 (Reuters) - Kronos Bio Inc KRON.O :
* KRONOS BIO REPORTS RECENT BUSINESS PROGRESS AND
FOURTH-QUARTER
AND FULL-YEAR 2022 FINANCIAL RESULTS
* KRONOS BIO - $247.9 MILLION IN CASH, CASH EQUIVALENTS AND
INVESTMENTS AS OF DECEMBER 31, 2022, PROVIDING EXPECTED CASH
RUNWAY INTO SECOND HALF OF 2025
* NET LOSS FOR Q4 OF 2022 WAS $0.56 PER SHARE
* Q4 EARNINGS PER SHARE VIEW $-0.59 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX3S8s6q
Further company coverage: KRON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kronos Bio
See all newsBrief: Kronos Bio Inc - Terminates Office Lease At 301 Binney Street - SEC Filing
Brief: Kronos Bio Inc - Enters Transition Agreement With Genentech
U.S. STOCKS ON THE MOVE - Ambarella, Dell, Nordstrom
U.S. STOCKS ON THE MOVE - Golden Ocean, Guess, Symbotic
U.S. STOCKS ON THE MOVE-HP, Urban Outfitters, 3D Systems